Phreesia reported first-quarter fiscal 2027 revenue of $130.9 million, representing a 13% increase compared to the previous year [1, 7].
The results signal a period of financial expansion for the Wilmington, Delaware-based healthcare technology company as it scales its payment-solution offerings. This growth suggests a strengthening market position for the firm's digital patient intake and payment tools.
The company reported an adjusted EBITDA of $30 million for the quarter [1]. Net income reached $3 million [4], while adjusted earnings per share were $0.05 [5]. This earnings figure exceeded the Zacks consensus estimate of $0.02 per share [6].
Growth for the period was driven by the robust expansion of payment-solution offerings and strategic financial moves [8]. These initiatives aimed to modernize how healthcare providers collect payments and manage patient data, a key priority for the company under CEO Chaim Indig.
The company's ability to beat consensus estimates reflects a higher-than-expected adoption rate of its technology suite. By increasing revenue by 13% [1], Phreesia has demonstrated a consistent ability to scale its operations across the U.S. healthcare market.
“Revenue for Q1 FY2027 reached $130.9 million”
Phreesia's ability to beat earnings expectations while maintaining a double-digit growth rate indicates a successful pivot toward integrated payment solutions. As healthcare providers seek to reduce administrative friction, the company's financial performance suggests that its specific software-as-a-service model is gaining traction in a competitive health-tech landscape.
